Cannon Kara 4
4 · ENZO BIOCHEM INC · Filed Feb 27, 2024
Insider Transaction Report
Form 4
Cannon Kara
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-02-23+150,000→ 451,297 total - Exercise/Conversion
Common Stock
2024-02-21+10,640→ 307,120 total - Tax Payment
Common Stock
2024-02-21−5,823→ 301,297 total
Holdings
- 45,065(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.
- [F2]Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements.
- [F3]The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control.